The market growth can also be attributed to technological advancements, such as the development of intraocular lenses, fundus cameras, and OCT devices. Furthermore, the increasing involvement of market players in expanding treatment solutions through strategic alliances is expected to present this market with a potential growth platform. Approximately 10% of the people suffering from eye disorders are expected to experience loss of vision despite the proper treatment, as per the statistics of the WHO, driving the clinical urgency to incorporate highly advanced ophthalmic devices. Furthermore, rising demand for minimally invasive and complication-free operative surgeries is expected to boost product demand. Due to the COVID-19 pandemic, the majority of the population’s screen time was increased, resulting in increased cases of various eye issues, which will support market growth over the forecast period.
The growing geriatric population is increasing the demand for ophthalmic devices, as they are more susceptible to age-related ophthalmic disorders. According to the National Institute on Aging (NIA), the geriatric population is expected to reach around 72 million by 2030. The increasing prevalence of diabetes and the incidence of diabetes-related blindness are predicted to fuel market growth. According to the World Health Organization, nearly 422 million people worldwide have diabetes, and the majority are living in low- and middle-income countries.
Increased screen time due to the lockdown measures in the COVID-19 pandemic has been associated with the onset and progression of various eye diseases, thus driving the demand for eye examinations. In June 2020, Johnson & Johnson Vision donated USD 320,000 to provide eye care to COVID-19-impacted patients. The organization conducted this donation to the Optometry Cares unit of the American Optometric Association (AOA) Foundation and the American Academy of Optometry Foundation (AAOF).
Request a free sample copy or view report summary: Ophthalmic Devices Market Report
Ophthalmic Devices Market Report Highlights
- Based on product, the optical coherence tomography scanners (OCT) segment dominated the global market in 2023
- The segment accounted for the largest share of over 23% of the overall revenue in 2023, which can be attributed to its wide range of applications
- The ophthalmoscopes segment is expected to witness significant growth from 2024 to 2030 on account of technological advancements
- The cataract application segment accounted for the largest revenue share in 2023 and is expected to continue its dominance over the forecast period
- This growth can be attributed to the increasing number of patients suffering from cataracts and high product adoption for cataract surgeries
Regional Insights
North America held the largest share in 2023. A high population of older adults and rising prevalence of chronic eye conditions resulting from factors, such as high stress and unhealthy lifestyles; ultimately leading to diabetic retinopathy, are considered high-impact rendering drivers for the market. In addition, the incorporation of new reimbursement models for ophthalmologic treatment and a stringent regulatory framework aimed at patients’ safety, is expected to fuel product demand in this region.
The U.S. possesses a well-developed healthcare system with leading academic institutions and research facilities. This encourages innovations in ophthalmic devices in terms of minimally invasive surgical techniques, advanced diagnostic instruments, and personalized medicine approaches, thereby propelling growth for the U.S. market. The U.S. spends significantly on healthcare compared to other developed countries, with total healthcare spending projected to reach $4.8 trillion by 2030. This translates into increased funding for specialized therapies and devices, including eye care.
Ophthalmic Devices Market Segmentation
Grand View Research has segmented the global ophthalmic devices market based on product, application, end-use, and region:
Ophthalmic Devices Product Outlook (Revenue, USD Million, 2018 – 2030)
- Optical Coherence Tomography Scanners
- Fundus Cameras
- Perimeters/Visual Field Analysers
- Autorefractors and Keratometers
- Ophthalmic Ultrasound Imaging Systems
- Ophthalmic A-Scan Ultrasound
- Ophthalmic B-Scan Ultrasound
- Ophthalmic Ultrasound Biomicroscopes
- Ophthalmic Pachymeters
- Tonometers
- Slit Lamps
- Phoropters
- Wavefront Aberrometers
- Optical Biometry Systems
- Ophthalmoscopes
- Lensmeters
- Corneal Topography Systems
- Specular Microscopes
- Retinoscopes
Ophthalmic Devices Application Outlook (Revenue, USD Million, 2018 – 2030)
- Cataract
- Vitreo Retinal Disorders
- Glaucoma
- Refractor Disorders
Ophthalmic Devices End-use Outlook (Revenue, USD Million, 2018 – 2030)
- Hospitals & Eye Clinics
- Academic & Research Laboratory
- Others
Ophthalmic Devices Regional Outlook (Revenue, USD Million, 2018 – 2030)
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Kuwait
List of Key Players in Ophthalmic Devices Market
- Johnson & Johnson Vision Care
- Alcon Vision LLC
- Carl Zeiss Meditec AG
- Bausch & Lomb Inc.
- Essilor International S.A.
- Ziemer Ophthalmic Systems Ltd.
- Nidek Co. Ltd.
- TOPCON Corporation
- Haag-Streit Group
Browse Full Report: Ophthalmic Devices Market Report